Cargando…
Comprehensive genomic profiling aids in treatment of a metastatic endometrial cancer
FGFR-TACC fusions, including FGFR3-TACC3, have been identified as potential oncogenic drivers and actionable alterations in a number of different cancer types. The clinical relevance of FGFR3-TACC3 fusions in endometrial cancer has not yet been described. Formalin-fixed, paraffin-embedded metastatic...
Autores principales: | Dhami, Jatinder, Hirshfield, Kim M., Ganesan, Shridar, Hellmann, Mira, Rojas, Veronica, Amorosa, Judith K., Riedlinger, Gregory M., Zhong, Hua, Ali, Siraj M., Pavlick, Dean, Elvin, Julia A., Rodriguez-Rodriguez, Lorna |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cold Spring Harbor Laboratory Press
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5880253/ https://www.ncbi.nlm.nih.gov/pubmed/29588307 http://dx.doi.org/10.1101/mcs.a002089 |
Ejemplares similares
-
Molecular Characterization of Epithelial Ovarian Cancer: Implications for Diagnosis and Treatment
por: Rojas, Veronica, et al.
Publicado: (2016) -
Durable Response to PD1 Inhibitor Pembrolizumab in a Metastatic, Metaplastic Breast Cancer
por: Gorshein, Elan, et al.
Publicado: (2021) -
Targetable alterations in invasive pleomorphic lobular carcinoma of the breast
por: Riedlinger, Gregory M., et al.
Publicado: (2021) -
Role of Biomarkers in the Development of PARP Inhibitors
por: Ganguly, Bratati, et al.
Publicado: (2016) -
Emerging Role of Genomic Rearrangements in Breast Cancer: Applying Knowledge from Other Cancers
por: Paratala, Bhavna S., et al.
Publicado: (2016)